Perceive Pharma
PrivateLast Round
Series A
Feb 18, 2025
Est. Valuation
$169M
Total Funding Raised
$15M
Company Overview
Perceive Pharma operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in February 2025.
Perceive Pharma is a drug discovery company that is advancing novel small molecule neuroprotective therapeutics, with lead pipeline programs in glaucoma and other ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perceive Pharma Comparables
Compare Perceive Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Bio | 82% | |
| Nura Bio | 60% | |
| Eli Lilly and Company | 59% |
For institutional investors. Book with your work email.
Perceive Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Perceive Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
| GV | Series A |
| Braidwell | Series A |
| Catalio Capital Management | Series A |
| Johnson & Johnson Innovation - JJDC | Series A |
| Foundation Fighting Blindness | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2025
$15M round led by Deerfield Management
For institutional investors. Book with your work email.
Perceive Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Perceive Pharma's valuation, stock price, and market status.
Is Perceive Pharma a public or private company?
Perceive Pharma is a private company.
What is the current stock price of Perceive Pharma?
Perceive Pharma is a private company, so its shares have no public market price. Caplight tracks Perceive Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Perceive Pharma worth (valuation)?
Perceive Pharma's valuation is estimated at $169.0M based on funding round data.
Can I buy Perceive Pharma stock?
Perceive Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Perceive Pharma's last funding round?
Perceive Pharma's most recent funding round was Series A on February 18, 2025.
Who are the main investors in Perceive Pharma?
Key investors in Perceive Pharma include Deerfield Management.
Will Perceive Pharma IPO soon?
No public IPO plans have been announced for Perceive Pharma.
How can I track Perceive Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Perceive Pharma's shares on secondary markets.